サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722864

経皮パッチの市場規模、シェア、動向、予測：タイプ、流通チャネル、用途、地域別、2025年～2033年

Transdermal Skin Patches Market Size, Share, Trends and Forecast by Type, Distribution Channel, Application, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
経皮パッチの市場規模、シェア、動向、予測：タイプ、流通チャネル、用途、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経皮パッチの世界市場規模は2024年に82億1,000万米ドルとなりました。今後、IMARC Groupは、2033年までに同市場が115億6,000万米ドルに達し、2025年から2033年にかけて3.69%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年には35.5%という大きな市場シェアを占めています。同市場が成長を遂げているのは、革新的な経皮技術を支える高度なヘルスケア・インフラがあるからです。慢性疾患の有病率が高いため、効果的で非侵襲的な治療オプションに対する需要が持続しています。これに加えて、製薬会社の強いプレゼンスと有利な規制枠組みが製品開発と規制承認を促進し、経皮パッチの世界市場シェアにおける同地域の重要性を確固たるものにしています。

経皮パッチとは、非侵襲的で使いやすいドラッグデリバリーのことで、一定量の治療薬をあらかじめ決められた時間にわたって血流に投与します。これらの薬剤は、バッキング、薬剤、メンブレン、接着剤、ライナー、化学増強剤や浸透剤、物理的補助剤、イオントフォレーシスのような微弱電流で構成されています。これらは、皮膚の特性やパッチのデザインに応じて、一定の拡散速度を提供します。現在では、化粧品、外用剤、経皮吸収型製剤として世界中で広く使用されています。

経皮パッチの市場動向：

経皮パッチは、心疾患やホルモン障害、片頭痛、パーキンソン病、アルツハイマー病、脳卒中、ヒト免疫不全ウイルス（HIV）、骨粗鬆症、レストレスレッグ症候群などの治療に有効です。したがって、これらの病気に苦しむ人口の割合が大幅に増加していることは、市場の成長を促す重要な要因の一つとなっています。さらに、これらのパッチは、医薬品を摂取するための伝統的な経口経路を避け、静脈内または非経口療法による不便さを軽減し、胃腸毒性、吐き気、嘔吐を防ぐのに役立ちます。さらに、投与が容易であるため、慢性疼痛や禁煙治療のための長期治療中の患者のコンプライアンスを向上させるために、経皮パッチの人気が高まっています。これとは別に、手頃なコストでより良い治療法を求める需要の高まりと、異なる薬剤クラスの臨床試験件数の大幅な増加が、市場にプラスの影響を与えています。さらに、感圧接着剤や浸透促進剤の導入により、製品の拡散が促進され、薬物保持能力が強化されるため、市場プレイヤーに有利な機会を提供し、今後数年間で経皮パッチの用途が世界中で拡大すると予想されます。

本レポートで扱う主な質問

  • 経皮パッチの市場の規模は？
  • 経皮パッチの市場の将来展望は？
  • 経皮パッチの市場を牽引する主要因は何か？
  • 経皮パッチの市場で最大のシェアを占める地域は？
  • 世界の経皮パッチの市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の経皮パッチ市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 単層貼付剤
  • 多層貼付剤
  • マトリックス
  • その他

第7章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンラインストア

第8章 市場内訳：用途別

  • 痛みの緩和
  • 喫煙の減少と禁煙の支援
  • 過活動膀胱
  • ホルモン療法
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • AdhexPharma
    • LTS Lohmann Therapie-Systeme AG
    • Luye Pharma Group
    • Medherant Limited
    • Nitto Denko Corporation
    • Noven Pharmaceuticals Inc.（Hisamitsu Pharmaceutical Co. Inc.）
    • Prosolus Inc.
    • Samyang Holdings Corporation
    • Tapemark
    • Teikoku Pharma USA Inc.（Teikoku Seiyaku Co. Ltd）
    • tesa SE（Beiersdorf AG）
    • Teva Pharmaceutical Industries Ltd
図表

List of Figures

  • Figure 1: Global: Transdermal Skin Patches Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Skin Patches Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Transdermal Skin Patches Industry: SWOT Analysis
  • Figure 82: Global: Transdermal Skin Patches Industry: Value Chain Analysis
  • Figure 83: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
  • Table 7: Global: Transdermal Skin Patches Market: Key Players
目次
Product Code: SR112025A5142

The global transdermal skin patches market size was valued at USD 8.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 11.56 Billion by 2033, exhibiting a CAGR of 3.69% during 2025-2033. North America currently dominates the market, holding a significant market share of 35.5% in 2024. The market is experiencing growth because of advanced healthcare infrastructure supporting innovative transdermal technologies. High prevalence of chronic conditions ensures sustained demand for effective, non-invasive treatment options. Besides this, strong presence of pharmaceutical companies and favorable regulatory frameworks drive product development and regulatory approvals, solidifying the region's significance in the global transdermal skin patches market share.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

Breakup by Type:

  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Matrix
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by Application:

  • Pain Relief
  • Smoking Reduction and Cessation Aid
  • Overactive Bladder
  • Hormonal Therapy
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the transdermal skin patches market?
  • 2.What is the future outlook of transdermal skin patches market?
  • 3.What are the key factors driving the transdermal skin patches market?
  • 4.Which region accounts for the largest transdermal skin patches market share?
  • 5.Which are the leading companies in the global transdermal skin patches market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Skin Patches Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single-layer Drug-in-Adhesive
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Multi-layer Drug-in-Adhesive
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Smoking Reduction and Cessation Aid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Overactive Bladder
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hormonal Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AdhexPharma
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 LTS Lohmann Therapie-Systeme AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Luye Pharma Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medherant Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Nitto Denko Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Prosolus Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Samyang Holdings Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tapemark
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 tesa SE (Beiersdorf AG)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Teva Pharmaceutical Industries Ltd
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis